Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Cannabidiol and Alcohol Use Disorder Phenotypes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on cannabidiol for alcohol use disorder, currently recruiting. The study aims to characterize phenotypes and responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Alcohol Use Disorder | Phase 2 | Status: RECRUITING